Inhibrx Biosciences, Inc. INBX
73.91 USD -3.75 (-4.83%)
As ofNov 17, 2026, 10:32 AM EST
74.36 Day range 78.21
57.30 52-week range 155.29
- YTD
- -6.44%
- 1 year
- -4.45%
INBX revenue history
Revenue is income from the company’s ordinary business activities.
1,300,000 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Some periods have no fiscal period label and are omitted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 1,300,000 | 1,100,000 | 550.00% |
| FY 2024 | 2024-12-31 | 200,000 | -1,600,000 | -88.89% |
| FY 2023 | 2023-12-31 | 1,800,000 | -392,000 | -17.88% |
| FY 2022 | 2022-12-31 | 2,192,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-15T07:00:35.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
